Pharmaceutical

Frontotemporal Dementia (FTD) drugs in development, 2024

GlobalData tracks 119 drugs in development for Frontotemporal Dementia (FTD) by 92 companies/universities/institutes. The top development phase for Frontotemporal Dementia (FTD) is preclinical, with 66 drugs in that stage.

Aug 31, 2024 - 04:00
GlobalData tracks 119 drugs in development for Frontotemporal Dementia (FTD) by 92 companies/universities/institutes. The top development phase for Frontotemporal Dementia (FTD) is preclinical, with 66 drugs in that stage.
Read the original article

Tags:

Previous Article

Generalized Pustular Psoriasis (GPP) drugs in development, 2024

Next Article

Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency drugs in development, 2024

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Eli Lilly’s partnership with Amazon to boost presence in diabetes and obesity markets

Eli Lilly’s partnership with Amazon to boost presence i...

Mar 20, 2024

FDA approves Pfizer’s RSV vaccine for older adults

FDA approves Pfizer’s RSV vaccine for older adults

May 31, 2023

Amgen in future of work: theme innovation strategy

Mar 5, 2024